A detailed history of Source Financial Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Source Financial Advisors LLC holds 2,026 shares of ABBV stock, worth $392,132. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,026
Previous 1,998 1.4%
Holding current value
$392,132
Previous $363,000 4.41%
% of portfolio
0.11%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$154.79 - $180.76 $4,334 - $5,061
28 Added 1.4%
2,026 $347,000
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $200,733 - $228,717
-1,256 Reduced 38.6%
1,998 $363,000
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $13,072 - $14,722
-95 Reduced 2.84%
3,254 $504,000
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $21,908 - $25,362
164 Added 5.15%
3,349 $499,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $27,032 - $33,639
-204 Reduced 6.02%
3,185 $429,000
Q1 2023

Apr 20, 2023

SELL
$144.61 - $166.54 $181,485 - $209,007
-1,255 Reduced 27.02%
3,389 $540,000
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $10,234 - $12,274
74 Added 1.62%
4,644 $750,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $4,294 - $4,925
32 Added 0.71%
4,570 $614,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $385,748 - $490,412
2,803 Added 161.56%
4,538 $695,000
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $20,060 - $24,890
-152 Reduced 8.06%
1,735 $282,000
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $14,395 - $18,214
-134 Reduced 6.63%
1,887 $256,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $1,064 - $1,207
10 Added 0.5%
2,021 $219,000
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $211,577 - $235,709
2,011 New
2,011 $226,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Source Financial Advisors LLC Portfolio

Follow Source Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Source Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Source Financial Advisors LLC with notifications on news.